Research programme: thyroid hormone analogues - OctamerAlternative Names: DIME; DIPE; Thyroid hormone analogues research programme - Octamer
Latest Information Update: 16 Jul 2016
At a glance
- Originator Octamer
- Class Hormones
- Mechanism of Action Tubulin polymerisation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in USA
- 03 Mar 2004 Thyroid hormone analogs research programme has been licensed to Crimson Pharma in China, Korea, Hong Kong, Taiwan, Singapore, and other countries and regions in Southeast Asia
- 29 Jul 2003 Preclinical trials in Cancer in USA (unspecified route)